Canada Markets open in 7 hrs 52 mins

Canntab Therapeutics Limited (TBF1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.47800.0000 (0.00%)
At close: 08:00AM CET
Full screen
Previous Close0.4780
Open0.4780
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.4780 - 0.4780
52 Week Range0.4020 - 0.7250
Volume200
Avg. Volume25
Market Cap17.976M
Beta (5Y Monthly)1.21
PE Ratio (TTM)N/A
EPS (TTM)-0.0800
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    CANNTAB OFFICIALLY LAUNCHES ITS ONLINE E-COMMERCE PLATFORM

    Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the official launch of its online e-commerce platform and web site at www.Canntab.ca.

  • GlobeNewswire

    Levitee Labs Partners with Canntab Therapeutics to Provide Alternatives to Opioids

    The agreement is anticipated to contribute to correcting the opioid crisis in Canada and serve as a foundation for both companies to potentially expand into new verticals in the futureLevitee Labs and Canntab Therapeutics have executed a services agreement resulting in Levitee Labs informing patients about the Canntab portfolio of therapeuticsLevitee Labs will offer the entire Canntab product lineup throughout all its clinics and pharmacies in Western Canada VANCOUVER, British Columbia, Jan. 10,

  • CNW Group

    CANNTAB DELIVERS 1st SHIPMENT TO THE ONTARIO CANNABIS STORE AND 2nd SHIPMENT TO AUSTRALIA

    Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to provide an update on its recent product deliveries for Ontario and Australia.